Does patient education increase antimuscarinic treatment persistence in overactive bladder syndrome?

Basit Öğe Kaydı
dc.authorscopusid55979875100
dc.authorscopusid8416588900
dc.authorscopusid55608201600
dc.authorscopusid56690269800
dc.authorscopusid25958732500
dc.contributor.authorYıldız, Tülin
dc.contributor.authorYazıcı, Cenk Murat
dc.contributor.authorDoğan, Çağrı
dc.contributor.authorÇetintaş, Müzeyyen
dc.contributor.authorMalak, Arzu
dc.date.accessioned2022-05-11T14:12:32Z
dc.date.available2022-05-11T14:12:32Z
dc.date.issued2015
dc.departmentYüksekokullar, Sağlık Yüksekokulu, Hemşirelik Bölümü
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı
dc.description.abstractOveractive bladder syndrome (OAB) is a chronic condition that requires long-term management. Patient education may have role in decreasing the unfavourable effects of long-term treatment of OAB. The aim of the study was to evaluate the effect of detailed patient education on the patients' persistence with antimuscarinic treatment for OAB. A total of 140 patients with the diagnosis of OAB were included in this study. Patients were randomly divided into two groups. Patients in Group 1 were given information by the same urology doctor about the disease and treatment. Patients in Group 2 were given information by a urology nurse. Patients were recalled in the first, third and sixth months of treatment. The treatment persistency was evaluated in the whole study population and between the groups. The persistency rates of the whole group were 88·6% in the first month, 65·7% in the third month and 45·7% in the sixth month. At the end of the sixth month, 42·8% of males and 47·1% of females were taking antimuscarinics (p = 0·580). The persistence rate of Groups 1 and 2 were 82·8 and 94·3% at the first month. (p = 0·034). It decreased to 31·4% in the first and 60% in the second group at the sixth month (p = 0·001). The persistence rate of antimuscarinic treatment is low. Patient education is simple and effective way of increasing persistence. Clinicians must pay attention to inform their patients about the disease and possible side effects of treatment. An educated health provider may be very helpful in educating patients for OAB. © 2014 John Wiley & Sons Ltd. and BAUN.
dc.identifier.doi10.1111/ijun.12058
dc.identifier.endpage91
dc.identifier.issn1749-7701
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-84931409377
dc.identifier.scopusqualityQ3
dc.identifier.startpage84
dc.identifier.urihttps://doi.org/10.1111/ijun.12058
dc.identifier.urihttps://hdl.handle.net/20.500.11776/5593
dc.identifier.volume9
dc.indekslendigikaynakScopus
dc.institutionauthorYıldız, Tülin
dc.institutionauthorYazıcı, Cenk Murat
dc.institutionauthorDoğan, Çağrı
dc.institutionauthorÇetintaş, Müzeyyen
dc.institutionauthorMalak, Arzu
dc.language.isoen
dc.relation.ispartofInternational Journal of Urological Nursing
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAntimuscarinic
dc.subjectEducation
dc.subjectOveractive bladder
dc.subjectPersistence
dc.subjectTreatment
dc.titleDoes patient education increase antimuscarinic treatment persistence in overactive bladder syndrome?
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
5593.pdf
Boyut:
269.82 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Sağlık Yüksekokulu Koleksiyonu
Tıp Fakültesi Koleksiyonu